Skip to content

Myriad Genetics MYGN Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$126M-16.7%$151.3M-2.3%$154.8M+84.9%$83.7M-17.1%$101M-9.7%
$123.8M+7.4%$115.3M-2.3%$118M-13.9%$137M+13.8%$120.4M-0.7%
$27.9M-8.8%$30.6M-3.2%$31.6M+10.1%$28.7M+1.4%$28.3M+2.9%
$34.7M+38.2%$25.1M-30.3%$36M+20.4%$29.9M-7.7%$32.4M+6.2%
$2M-83.3%$12M-13.0%$13.8M-3.5%$14.3M0.0%$14.3M-12.8%
$312.8M-6.0%$332.6M-3.5%$344.8M+21.3%$284.3M-1.0%$287.2M-3.6%
$111.5M-2.2%$114M+2.3%$111.4M-1.4%$113M-0.9%$114M-2.9%
$90.5M+3.0%$87.9M+5.5%$83.3M+4.9%$79.4M-4.9%$83.5M-23.8%
$51M+3.2%$49.4M-2.4%$50.6M-1.2%$51.2M-4.1%$53.4M-2.9%
$47.1M-8.7%$51.6M0.0%$51.6M0.0%$51.6M-82.0%$286.3M0.0%
$145.7M-5.0%$153.4M-5.9%$163.1M-4.1%$170.1M-33.9%$257.5M-1.9%
$5.6M0.0%$5.6M-15.2%$6.6M-7.0%$7.1M-7.8%$7.7M-9.4%
$673.7M-4.7%$706.6M-3.0%$728.1M+7.5%$677.3M-32.7%$1.01B-2.1%
$32.6M+8.7%$30M-5.7%$31.8M+2.9%$30.9M+10.0%$28.1M-13.0%
$39.8M-22.3%$51.2M+8.2%$47.3M+16.8%$40.5M-5.8%$43M-63.9%
$7.1M+2.9%$6.9M-12.7%$7.9M-12.2%$9M-17.4%$10.9M-14.8%
$6.6M+15.8%$5.7M+11.8%$5.1M0.0%$5.1M-43.3%$9M+76.5%
$130.2M-2.7%$133.8M-9.6%$148M-26.0%$199.9M+32.3%$151.1M-7.9%
$120.3M+0.3%$119.9M+0.3%$119.5M$0-100%$59.3M+49.7%
$84.1M+1.3%$83M-2.2%$84.9M-1.5%$86.2M-1.4%$87.4M-0.6%
$1.7M-10.5%$1.9M+11.8%$1.7M-10.5%$1.9M-5.0%$2M-9.1%
$336.3M-0.7%$338.6M-4.7%$355.3M+22.9%$289.2M-4.0%$301.2M-7.7%
150M+16,567%900K-99.4%150M0.0%150M0.0%150M+16,567%
$1.49B+0.2%$1.49B+0.1%$1.49B+0.8%$1.47B+0.9%$1.46B+0.3%
-$1.16B-3.0%-$1.12B-0.7%-$1.11B-2.5%-$1.09B-43.7%-$756.9M0.0%
$700K-12.5%$800K+900%-$100K0.0%-$100K+83.3%-$600K+25.0%
$337.4M-8.3%$368M-1.3%$372.8M-3.9%$388.1M-44.9%$704.9M+0.5%
$673.7M-4.7%$706.6M-3.0%$728.1M+7.5%$677.3M-32.7%$1.01B-2.1%
$5.6M0.0%$5.6M-15.2%$6.6M-7.0%$7.1M-7.8%$7.7M-9.4%
$512M0.0%$511.9M-0.8%$515.9M-0.3%$517.7M-13.1%$595.9M+0.8%
$51M+3.2%$49.4M-2.4%$50.6M-1.2%$51.2M-4.1%$53.4M-2.9%
$145.7M-5.0%$153.4M-5.9%$163.1M-4.1%$170.1M-33.9%$257.5M-1.9%
$145.7M-5.0%$153.4M-5.9%$163.1M-4.1%$170.1M-33.9%$257.5M-1.9%
$51M+3.2%$49.4M-2.4%$50.6M-1.2%$51.2M-4.1%$53.4M-2.9%
$5.6M0.0%$5.6M-15.2%$6.6M-7.0%$7.1M-7.8%$7.7M-9.4%
$202M0.0%$201.9M+3.7%$194.7M+1.2%$192.4M-2.6%$197.5M-13.0%
$51M+3.2%$49.4M-2.4%$50.6M-1.2%$51.2M-4.1%$53.4M-2.9%
$5.6M0.0%$5.6M-15.2%$6.6M-7.0%$7.1M-7.8%$7.7M-9.4%
$39.8M-22.3%$51.2M+8.2%$47.3M+16.8%$40.5M-5.8%$43M-25.1%
$4.7M0.0%$4.7M-16.1%$5.6M-1.8%$5.7M-5.0%$6M-7.7%
$90.5M-6.6%$96.9M-10.5%$108.3M+7.7%$100.6M-10.3%$112.1M-5.8%
$90.5M-6.6%$96.9M-10.5%$108.3M+7.7%$100.6M-10.3%$112.1M-5.8%
$39.8M-22.3%$51.2M+8.2%$47.3M+16.8%$40.5M-5.8%$43M-25.1%
$211.5M+0.8%$209.8M-1.2%$212.3M+37.3%$154.6M-1.9%$157.6M+12.3%
94.4M+1.0%93.5M+0.4%93.1M0.0%93.1M+1.0%92.2M+1.0%
$1.49B+0.2%$1.49B+0.1%$1.49B+0.8%$1.47B+0.9%$1.46B+0.3%
$900K0.0%$900K0.0%$900K0.0%$900K0.0%$900K0.0%
700K0.0%700K0.0%700K0.0%700K0.0%700K0.0%
$13.380.0%$13.380.0%$13.380.0%$13.380.0%$13.380.0%
$202M0.0%$201.9M+3.7%$194.7M+1.2%$192.4M-2.6%$197.5M-13.0%
$4.7M0.0%$4.7M-16.1%$5.6M-1.8%$5.7M-5.0%$6M-7.7%
$94.4M+1.0%$93.5M+0.4%$93.1M0.0%$93.1M+1.0%$92.2M+1.0%
$94.4M+1.0%$93.5M+0.4%$93.1M0.0%$93.1M+1.0%$92.2M+1.0%
$366.3M+2.2%$358.5M+1.6%$352.8M+1.5%$347.6M+2.7%$338.4M+2.9%
$512M0.0%$511.9M-0.8%$515.9M-0.3%$517.7M-13.1%$595.9M+0.8%
$20.1M+30.5%$15.4M-36.6%$24.3M+2.1%$23.8M-14.1%$27.7M+22.6%
$19.3M-3.0%$19.9M+7.6%$18.5M+2.8%$18M-4.8%$18.9M-5.0%
$700K0.0%$700K0.0%$700K0.0%$700K0.0%$700K0.0%
$13.380.0%$13.380.0%$13.380.0%$13.380.0%$13.380.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Myriad Genetics's total assets?
Myriad Genetics (MYGN) holds $673.7M in total assets, down 33.0% year over year.
How much debt does Myriad Genetics have?
Myriad Genetics carries $211.5M in total debt against $337.4M of shareholders' equity, a debt-to-equity ratio of 0.63.
How much cash does Myriad Genetics have?
Myriad Genetics holds $126.0M in cash and equivalents.
Can Myriad Genetics cover its short-term obligations?
Its current ratio is 2.40 — current assets exceed current liabilities.
Where does Myriad Genetics's balance sheet data come from?
Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.